Evanston, Illinois
United States
46
2025-05-08
The entities that hold a legal rights for patent applications filed by inventor Bogdan Andrew:
Andrew Bogdan from Evanston, US has applied for patents for these inventions. The list has both pending applications and granted patents:
BROMODOMAIN INHIBITORS
#2 | 2025-04-17PROTEIN TYROSINE PHOSPHATASE INHIBITORS AND METHODS OF USE THEREOF
#3 | 2025-02-06PROTEIN TYROSINE PHOSPHATASE INHIBITORS AND METHODS OF USE THEREOF
#4 | 2025-01-16PROTEIN TYROSINE PHOSPHATASE INHIBITORS AND METHODS OF USE THEREOF
#5 | 2024-05-16Pyrrolidine Main Protease Inhibitors as Antiviral Agents
#6 | 2024-02-08Modulators of the Cystic Fibrosis Transmembrane Conductance Regulator Protein and Methods of Use
#7 | 2023-03-30Bromodomain Inhibitors
#8 | 2023-01-19PROTEIN TYROSINE PHOSPHATASE INHIBITORS AND METHODS OF USE THEREOF
#9 | 2022-07-07Modulators of the Cystic Fibrosis Transmembrane Conductance Regulator Protein and Methods of Use
#10 | 2021-08-19Bromodomain Inhibitors
#11 | 2021-08-05Modulators of the Cystic Fibrosis Transmembrane Conductance Regulator Protein and Methods of Use
#12 | 2021-03-11TETRACYCLIC BROMODOMAIN INHIBITORS
#13 | 2020-09-17TETRACYCLIC BROMODOMAIN INHIBITORS
#14 | 2020-09-03Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use
#15 | 2020-09-03Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use
#16 | 2020-09-03Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use
#17 | 2020-09-03Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use
#18 | 2020-02-13Bromodomain Inhibitors
#19 | 2019-12-26TETRACYCLIC BROMODOMAIN INHIBITORS
#20 | 2019-10-17Substituted Pyrrolidines and Methods of Use
#21 | 2019-05-09Substituted Tricyclics and Method of Use
#22 | 2019-05-02Substituted Chromanes and Method of Use
#23 | 2019-03-14Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use
#24 | 2019-02-21Heteroaryl substituted pyridines and methods of use
#25 | 2019-01-10BROMODOMAIN INHIBITORS
#26 | 2018-11-226-HETEROARYLOXY- OR 6-ARYLOXY-QUINOLINE-2-CARBOXAMIDES AND METHOD OF USE
#27 | 2018-10-18TETRACYCLIC BROMODOMAIN INHIBITORS
#28 | 2018-08-30Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use
#29 | 2018-08-30Modulators of the Cystic Fibrosis Transmembrane Conductance Regulator Protein and Methods of Use
#30 | 2018-04-12Substituted pyrrolidines and methods of use
#31 | 2018-04-12Substituted pyrrolidines and methods of use
#32 | 2018-02-08Substituted Tricyclics and Method of Use
#33 | 2017-12-07Heteroaryl substituted pyridines and methods of use
#34 | 2017-10-26Modulators of cystic fibrosis transmembrane conductance regulator protein
#35 | 2017-08-106-HETEROARYLOXY- OR 6-ARYLOXY-QUINOLINE-2-CARBOXAMIDES AND METHOD OF USE
#36 | 2017-07-06SUBSTITUTED CHROMANES AND METHOD OF USE
#37 | 2017-01-19Substituted tricyclics and method of use
#38 | 2016-12-086-heteroaryloxy- or 6-aryloxy-quinoline-2-carboxamides and method of use
#39 | 2016-11-17Bromodomain inhibitors
#40 | 2016-05-05Substituted chromanes and method of use
#41 | 2016-02-11Substituted 1,4,10-triazadibenzo[cd,f]azulenes, substituted 1,4,5,10-tetraazadibenzo[cd,f]azulenes and substituted 1,4,5,7,10-pentaazadibenzo[cd,f]azulenes as bromodomain inhibitors
#42 | 2015-08-066-heteroaryloxy- or 6-aryloxy-quinoline-2-carboxamides and method of use
#43 | 2015-06-11Bromodomain inhibitors
#44 | 2015-06-04BROMODOMAIN INHIBITORS
#45 | 2014-09-11Bromodomain inhibitors
#46 | 2014-03-13GLYCYRRHETINIC ACID DERIVATIVES AND METHODS OF USE THEREOF
687208 โ